Rutvij A. Khanolkar

1

Article

1

Comment

Rutvij is a final-year MD student at the University of Calgary. He is a published researcher in the fields of Emergency and Internal Medicine. His recent research has focused on health resource utilization and overdiagnosis during the COVID19 pandemic, with a focus on the efficacy of public health measures for preventing viral respiratory illnesses such as chronic obstructive pulmonary disease, influenza, and pneumonia.

Experience

  • –present
    Medical Student, University of Calgary

Education

  • 2016 
    University of Toronto, Bachelor of Science

Publications

  • 2022
    Emerging evidence for non-pharmacologic interventions in reducing the burden of respiratory illnesses, Internal & Emergency Medicine
  • 2021
    Clinical Outcomes from Dose-Reduced Radiotherapy to the Prostate in Elderly Patients with Localized Prostate Cancer, Current Oncology
  • 2021
    A biomarker-guided, prospective, phase 2 trial of pre-emptive graft-versus-host disease therapy using anti-thymocyte globulin, Cytotherapy
  • 2021
    Impact of FLT3 internal tandem duplication and NPM1 mutations in acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation, Cytotherapy
  • 2021
    Excessive waitlists and delays to treatment with low-dose-rate brachytherapy predict an increased risk of recurrence and metastases in intermediate-risk prostatic carcinoma, Clinical & Translational Radiation Oncology
  • 2020
    Ecological Succession of Polymicrobial Communities in the Cystic Fibrosis Airways, mSystems

Contact Rutvij for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision